Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Sarcoma × Temozolomide × Clear all

Phase

Status

Completed 9 Recruiting 4 Active not recruiting 3 Withdrawn 2 Unknown 2 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Glioblastoma 1

Interventions

tivozanib 1 pembrolizumab 1 pegamotecan 1 atezolizumab 1 Vincristine 1 Temozolomide 1 Health Care Economics and Organizations 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04890093 2026-03-16

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Suspended

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡